Review: taking Abilify and Restoril together


Summary

Drug interactions are reported among people who take Abilify and Restoril together. This review analyzes the effectiveness and drug interactions between Abilify and Restoril. It is created by eHealthMe based on reports of 446 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Abilify and Restoril >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Abilify

Abilify has active ingredients of aripiprazole. It is often used in bipolar disorder. (latest outcomes from Abilify 29,792 users)

Restoril

Restoril has active ingredients of temazepam. It is often used in insomnia. (latest outcomes from Restoril 7,540 users)

On Jul, 24, 2016

446 people who take Abilify, Restoril are studied.


Number of reports submitted per year:

Abilify and Restoril drug interactions.

Drug effectiveness over time:

Abilify:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Restoril:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 66.0% - (2 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Abilify:
  • female: 25.0% - (1 of 4 people)
  • male: 0.0% - (0 of 5 people)
Restoril:
  • female: 33.0% - (2 of 6 people)
  • male: 20.0% - (1 of 5 people)

Drug effectiveness by age:

Abilify:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 20.0% - (1 of 5 people)
  • 60+: 0.0% - (0 of 0 people)
Restoril:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 40.0% - (2 of 5 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • death
  • respiratory arrest
  • myocardial infarction
  • sleep apnoea syndrome
  • delusion
  • hallucination
  • psychotic disorder
  • abnormal behaviour
  • anaphylactic reaction
  • arthralgia
1 - 6 months:
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • confusional state
  • aggression
  • delusion
  • psychotic disorder
  • rhabdomyolysis
  • anxiety
  • bipolar disorder
  • hyperglycaemia
6 - 12 months:
  • costochondritis
  • diabetes mellitus
  • urinary incontinence
  • alcoholic pancreatitis
  • anxiety
  • balance disorder
  • blood cholesterol increased
  • blood glucose abnormal
  • cardiac failure congestive
  • death
1 - 2 years:
  • blood cholesterol increased
  • type 2 diabetes mellitus
  • cardiac disorder
  • diabetes mellitus
  • coma
  • confusional state
  • coordination abnormal
  • decubitus ulcer
  • gait disturbance
  • septic shock
2 - 5 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • neuropathy peripheral
  • asthenia
  • blood pressure abnormal
  • gastrooesophageal reflux disease
  • hyperglycaemia
  • antisocial behaviour
  • blood glucose increased
  • death
5 - 10 years:
  • anxiety
  • cholecystitis
  • deep vein thrombosis
  • emotional distress
  • gallbladder disorder
  • pain
  • pulmonary embolism
  • thrombosis
  • antisocial behaviour
  • depression
not specified:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • anxiety
  • back pain
  • nausea
  • pain in extremity
  • gastrooesophageal reflux disease
  • blood cholesterol increased
  • chest pain
  • depression

Most common drug interactions by gender *:

female:
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • diabetes mellitus
  • nausea
  • anxiety
  • back pain
  • gastrooesophageal reflux disease
  • pain in extremity
  • vomiting
  • confusional state
male:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • anxiety
  • obsessive-compulsive disorder
  • neuropathy peripheral
  • psychotic disorder
  • paranoia
  • hallucination, auditory
  • blood creatine phosphokinase increased
  • catatonia

Most common drug interactions by age *:

0-1:
  • pancreatitis
10-19:
  • confusional state
  • delusion
  • hallucination, auditory
  • homicidal ideation
  • abnormal behaviour
  • aggression
  • agitation
  • anger
  • anxiety
  • blood prolactin increased
20-29:
  • obesity
  • diabetes mellitus
  • type 2 diabetes mellitus
  • insomnia
  • arthritis
  • blood cholesterol increased
  • blood triglycerides increased
  • c-reactive protein increased
  • gallbladder disorder
  • hypertension
30-39:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • back pain
  • anxiety
  • nausea
  • vomiting
  • gastrooesophageal reflux disease
  • pain
  • fall
  • insomnia
40-49:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • neuropathy peripheral
  • depression
  • hyperlipidaemia
  • obesity
  • chest pain
  • hypertension
  • anxiety
50-59:
  • type 2 diabetes mellitus
  • dizziness
  • diabetes mellitus
  • headache
  • back pain
  • diabetes mellitus inadequate control
  • anxiety
  • decreased appetite
  • exostosis
  • gastrooesophageal reflux disease
60+:
  • confusional state
  • diabetes mellitus
  • type 2 diabetes mellitus
  • anxiety
  • blood cholesterol increased
  • gait disturbance
  • syncope
  • hyperglycaemia
  • cardiac disorder
  • cellulitis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Abilify and Restoril?

Can you answer these questions?

More questions for: Abilify, Restoril

You may be interested in these reviews

More reviews for: Abilify, Restoril

On eHealthMe, Abilify (aripiprazole) is often used to treat bipolar disorder. Restoril (temazepam) is often used to treat insomnia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.